On paper, at least, Aivela is giving the smart ring category a different spin, shifting it from passive health tracking toward more active control.

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

The Lenovo Legion Pro Rollable, previously rumored but officially unveiled at CES 2026, is easily one of the most intriguing ...

There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

The Indian government has banned oral Nimesulide formulations above 100mg, including tablets and syrups, citing serious liver ...

We recently published 10 Stocks Beating Wall Street at its Own Game. Hinge Health Inc. (NYSE:HNGE) is one of the best-performing stocks on Wednesday. Hinge Health snapped a five-day losing streak on ...

Hinge Health, Inc. Class A ( (HNGE)) has issued an update. On November 12, 2025, Hinge Health, Inc. announced a $250 million share repurchase program, approved by its Board of Directors on November 10 ...